title: Successful treatment of refractory subcutaneous panniculitis-like T-cell lymphoma with allogeneic peripheral blood stem cell transplantation from HLA-mismatched sibling donor.
authors.forename: Michiko
authors.initials: M
authors.lastname: Ichii
authors.forename: Kazuo
authors.initials: K
authors.lastname: Hatanaka
authors.forename: Masami
authors.initials: M
authors.lastname: Imakita
authors.forename: Yasutaka
authors.initials: Y
authors.lastname: Ueda
authors.forename: Bun-Ichiro
authors.initials: B
authors.lastname: Kishino
authors.forename: Toshiharu
authors.initials: T
authors.lastname: Tamaki
mesh_terms: D000293:Adolescent; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000008:administration & dosage / Q000627:therapeutic use; D001706:Biopsy; D003520:Cyclophosphamide / Q000008:administration & dosage; D004317:Doxorubicin / Q000008:administration & dosage; D005047:Etoposide / Q000008:administration & dosage; D005260:Female; D006680:HLA Antigens / Q000737:chemistry*; D006650:Histocompatibility Testing; D006801:Humans; D016399:Lymphoma, T-Cell / Q000628:therapy*; D015434:Panniculitis / Q000628:therapy*; D036102:Peripheral Blood Stem Cell Transplantation / Q000379:methods*; D011241:Prednisone / Q000008:administration & dosage; D035781:Siblings; D014019:Tissue Donors; D014184:Transplantation, Homologous; D014750:Vincristine / Q000008:administration & dosage
chemical_list: D006680:HLA Antigens; D014750:Vincristine; D005047:Etoposide; D004317:Doxorubicin; D003520:Cyclophosphamide; D011241:Prednisone